Page 455 - Read Online
P. 455

Poddar et al.                                                                                                                                                        Carcinoma tongue in renal transplant recipient

           The incidence of malignancy increases gradually for   REFERENCES
           ten years after the transplant and becomes as high
           as 13.8 fold higher in such patients as compared to   1.   Chapman JR, Webster AC. Cancer after renal transplantation: the next
           the  normal  population.  The  cumulative  frequency   challenge. Am J Transplant 2004;4:841-2.
           increases with  increase in  duration of  follow-up.   2.   Malleshappa  P,  Aghariya M,  Tampi C, Shah BV. Squamous cell
           This patient developed his cancer 18 years after      carcinoma  of tongue in a renal transplant recipient.  Indian J Med
                     [9]
           transplant.   Other  risk  factors  attributable  to   Paediatr Oncol 2009;30:136-7.
           development of malignancy in these patients is     3.   Lee YW, Gisser SD. Squamous cell  carcinoma  of the  tongue  in a
           advancing age, viral infections, cigarette smoking, and   nine year renal transplant survivor: a case report with a discussion of
                                                   [10]
           transmission of malignancy from donor cells.  Thus,   the risk of development of epithelial carcinomas in renal transplant
           strict follow-up and vigilance for signs and symptoms   survivors. Cancer 1978;41:1-6.
           of malignancy should be followed in patients with   4.   Rama I, Grinyó JM. Malignancy after renal transplantation: the role of
           organ transplantation on immunosuppressive drugs,     immunosuppression. Nat Rev Nephrol 2010;6:511-9.
           even after decades of transplant.                  5.   Sheil  AG. Cancer report 2001. In: Ross GR, editor.  ANZDATA

           Financial support and sponsorship                     Registry Report 2001. Adelaide, South Australia: Australia and New
           Nil.                                                  Zealand Dialysis and Transplant Registry; 2001. p. 84-90.
                                                              6.   Tsai  MC, Chen  YT,  Chien  YS, Chen  TC,  Hu  TH.  Hepatitis  B
           Conflicts of interest                                 virus infection  and renal transplantation.  World J Gastroenterol
           There are no conflicts of interest.                   2010;16:3878-87.
                                                              7.   Silveira FP, Husain S. Fungal infections in solid organ transplantation.
           Patient consent                                       Med Mycol 2007;45:305-20.
           Patient consent was obtained from the patient.     8.   Shoham  S, Marr  KA. Invasive  fungal  infections  in  solid  organ
                                                                 transplant recipients. Future Microbiol 2012;7:639-55.
           Ethics approval                                    9.   Yang TC, Shu KH, Cheng CH, Wu MJ, Lian JD. Malignancy following
           Ethics approval was obtained  from the institutional   renal transplantation. Zhonghua Yi Xue Za Zhi (Taipei) 1998;61:281-8.
           ethical  committee for preparation  and publication  of   10.  Danpanich E, Kasiske BL. Risk factors for cancer in renal transplant
           this paper.                                           recipients. Transplantation 1999;68:1859-64.










































                           Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ November 25, 2016      445
   450   451   452   453   454   455   456   457   458   459   460